Pfizer loses another drug
Pfizer will be taking another financial hit soon.
The company has decided to discontinue the manufacturing and distribution of Exubera, an inhaled-insulin product.
They reportedly state it is because it has failed to gain acceptance among patients and physicians.
Pfizer originally thought this product would be much better accepted and help eliminate insulin injections but they evidently miscalculated patients dislike for shots.
It surely couldn’t have been the cost, poor formulary coverage, hassles to physician offices when trying to order it or the very inconvenient device itself as shown in this picture.
The company has decided to discontinue the manufacturing and distribution of Exubera, an inhaled-insulin product.
They reportedly state it is because it has failed to gain acceptance among patients and physicians.
Pfizer originally thought this product would be much better accepted and help eliminate insulin injections but they evidently miscalculated patients dislike for shots.
It surely couldn’t have been the cost, poor formulary coverage, hassles to physician offices when trying to order it or the very inconvenient device itself as shown in this picture.
Patients currently receiving this product will need to transition to another medication to control their diabetes.
posted by Anonymous at 5:54 AM
0 Comments:
Post a Comment
<< Home